生命退化退化:产品和途径
Leo Štefan1, Ivan Sušanj1, Jadranka Buljević1
1JGL d.d. Jadran Galenski Laboratorij, 51000 Rijeka, Croatia.
Pharmaceutics
|October 29, 2025
概括
这项研究确定了 lifitegrast 中的关键降解点,这是一种干眼疾病治疗方法. 了解这些弱点有助于确保药物安全.
科学领域:
- 制药化学 制药化学 制药化学
- 药物降解研究 药物降解研究
- 光谱学分析的分析.
背景情况:
- 利菲特格拉斯特是一种用于干眼疾病的新型治疗剂.
- 由于其有效性和安全性,它已经获得了大量的科学和监管关注.
- 了解其降解途径对于稳定性评估至关重要.
研究的目的:
- 在各种压力条件下调查liftegrast的降解途径.
- 识别和描述降解产品和弱点.
- 评估已识别的降解剂的潜在毒性.
主要方法:
- 使用了核磁共振 (NMR) 谱学和质谱学.
- 在标准到极端条件下进行了强制降解研究.
- 计算DFT和BDE分析被用来阐明降解机制.
主要成果:
- 鉴定了9种新的和3种已知的生物化物降解产品.
- 鉴定出N1-C40胺基键是水解的主要部位.
- 在piperidine和benzofuran环中发现了氧化脆弱性.
- 确定了降解产品DP7的修订结构.
结论:
- 在lifitegrast中阐明了关键的水解和氧化弱点.
- 发现降解产品具有与lifitegrast.com相比的可比性或较低的预测毒性.
- 这项研究有助于理解生命的稳定性和安全性.
相关概念视频
Amino Acid Biosynthetic Pathways
1.1K
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
1.1K
Respiration Pathways
708
Cellular respiration is a fundamental metabolic process that enables organisms to generate energy from organic molecules. One of its central pathways is the tricarboxylic acid (TCA) cycle, also known as the Krebs cycle, which plays a crucial role in energy production and biosynthetic processes.Conversion of Pyruvate to Acetyl-CoAThe pyruvate generated from glycolysis undergoes oxidative decarboxylation by the pyruvate dehydrogenase complex, producing acetyl-CoA, one molecule of NADH, and one...
708
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
The Proteasome
4.4K
4.4K
Export of Misfolded Proteins out of the ER
5.0K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.0K


